Gilder Gagnon Howe & Co’s Apollo Endosurgery, Inc. APEN Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-371,653	Closed	-$3.69M	–	345
2023 Q1	$3.69M	Sell	371,653 -1,352	-0.4%	-$13.4K	0.06%	149
2022 Q4	$3.72M	Sell	373,005 -88,582	-19%	-$661K	0.07%	149
2022 Q3	$2.54M	Sell	461,587 -1,302	-0.3%	-$7.22K	0.04%	162
2022 Q2	$1.69M	Sell	462,889 -43,469	-9%	-$205K	0.03%	182
2022 Q1	$3.06M	Sell	506,358 -22,001	-4%	-$134K	0.03%	205
2021 Q4	$4.45M	Buy	528,359 +314,306	+147%	+$2.75M	0.03%	226
2021 Q3	$1.94M	Buy	214,053 +55,717	+35%	+$479K	0.01%	301
2021 Q2	$1.28M	Buy	+158,336	New	+$1.09M	0.01%	322

Gilder Gagnon Howe & Co's APEN Position: Q2 2023 in Review

Gilder Gagnon Howe & Co sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 371,653 shares — an estimated $3.69M sold.

Gilder Gagnon Howe & Co first reported a position in APEN in Q2 2021 and held it in 8 quarters. The position peaked at $4.45M in Q4 2021. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.

Gilder Gagnon Howe & Co reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
Gilder Gagnon Howe & Co sold 371,653 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $3.69M.
Gilder Gagnon Howe & Co first reported a position in Apollo Endosurgery, Inc. in Q2 2021 and held it in 8 quarters.
Gilder Gagnon Howe & Co's Apollo Endosurgery, Inc. position peaked at $4.45M in Q4 2021.
0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.

Based on Gilder Gagnon Howe & Co's 13F filing for Q2 2023, filed 14 Aug 2023.